Home › Executives › Dr. Yvonne Greenstreet
Dr. Yvonne Greenstreet

Dr. Yvonne Greenstreet

Chief Executive Officer, Alnylam Pharmaceuticals

Alnylam Pharmaceuticals•Cambridge, Massachusetts, United States

View LinkedIn Profile
Experience34+ Years
LevelLeadership

Executive Overview

CEO at Alnylam Pharmaceuticals

Career Timeline

Professional employment history
  • Alnylam PharmaceuticalsCurrent
    2016–Present· 10 yrs 8 mos
    • Chief Executive OfficerCurrent
      2022–Present
    • President and Chief Operating Officer
      2020–2022
    • Chief Operating Officer
      2016–2020
  • Highgate LLC
    2014–2016· 2 yrs
    • Managing Director, Founder
      2014–2016
  • Pfizer
    2010–2013· 3 yrs
    • SVP and Head of Medicines Development
      2010–2013
  • GSK
    2000–2010· 10 yrs
    • Senior Vice President and Chief of Strategy
      2008–2010
    • Senior Vice President, Medicine Development
      2004–2008
    • Chief Medical Officer for Europe (Head of Medicines Development and Medical Affairs)
      2003–2004
    • Vice President and Medical Director for the UK
      2000–2003
  • GSK
    1992–1999· 7 yrs
    • Clinical Development Director
      1996–1999
    • Head of Heath Management
      1994–1996
    • International Medical Affairs Manager
      1992–1994

Education

MBA

INSEAD

MBChB

Medicine

University of Leeds

Executive Relationship Map

Reports To
Dr. Yvonne Greenstreet
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer

Executive Network Preview

BizKonnect has mapped this leadership network including reporting hierarchies, peer connections, and cross-functional relationships.

Verified Contact Information
Email & Direct Dial
Org Chart & Reporting Lines
Buying Committee Insights
AI-Powered Account Mapping

Skills & Expertise

13 of 13 skills
Medical AffairsTechnology TransferDrug DiscoveryProduct LaunchOncologyR&DBiopharmaceuticalsDrug DevelopmentClinical DevelopmentClinical TrialsUrologyPharmaceutical IndustryBiotechnology